According to recent studies, overexpression of SHBG downregulated lipogenesis and reduced hepatic steatosis, suggesting its protective role in NAFLD/MASLD [48,67]. This evidence concerns the gene SHBG and metabolic dysfunction-associated steatotic liver disease.